Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors
文献类型：期刊论文
| 作者 | Liang, Xuewu1,2; Liu, Hong1 ; Zhang, Yingjie2
|
| 刊名 | FUTURE MEDICINAL CHEMISTRY
 |
| 出版日期 | 2019-08-01 |
| 卷号 | 11期号:15页码:1849-1852 |
| 关键词 | dual inhibitors HDAC hematological malignancies JAK multiple target drugs |
| ISSN号 | 1756-8919 |
| DOI | 10.4155/fmc-2019-0168 |
| 通讯作者 | Liu, Hong(hliu@mail.shcnc.ac.cn) ; Zhang, Yingjie(zhangyingjie@sdu.edu.cn) |
| WOS关键词 | KINASE 2 JAK2 ; ACTIVATION ; DESIGN ; PACRITINIB ; LEUKEMIA |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000492209100002 |
| 出版者 | FUTURE SCI LTD |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/281805]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Liu, Hong; Zhang, Yingjie |
| 作者单位 | 1.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China 2.Shandong Univ, Dept Med Chem, Key Lab Chem Biol, Minist Educ,Sch Pharm, Jinan 250012, Shandong, Peoples R China |
| 推荐引用方式 GB/T 7714 | Liang, Xuewu,Liu, Hong,Zhang, Yingjie. Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors[J]. FUTURE MEDICINAL CHEMISTRY,2019,11(15):1849-1852. |
| APA | Liang, Xuewu,Liu, Hong,&Zhang, Yingjie.(2019).Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors.FUTURE MEDICINAL CHEMISTRY,11(15),1849-1852. |
| MLA | Liang, Xuewu,et al."Novel-targeted therapy for hematological malignancies with JAK and HDAC dual inhibitors".FUTURE MEDICINAL CHEMISTRY 11.15(2019):1849-1852. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。